News

Tool provides info for cancer patients, survivors


 

Cancer patient

receiving treatment

Photo by Rhoda Baer

The American Cancer Society and National Cancer Institute have launched an online tool for cancer patients and survivors.

The tool, Springboard Beyond Cancer, was designed to help these individuals address medical, psychosocial, and wellness needs during and after treatment.

Springboard Beyond Cancer provides information to help cancer patients and survivors manage ongoing cancer-related symptoms, deal with stress, ensure healthy behavior, communicate better with healthcare teams, and seek support from friends and family.

“With Springboard Beyond Cancer, we want to empower cancer survivors by giving them the information they need to help identify issues, set goals, and create a plan to more smoothly navigate the cancer journey and take control of their health,” said Corinne Leach, PhD, a behavioral scientist and strategic director in the Behavioral Research Center at the American Cancer Society.

“We hope that Springboard Beyond Cancer, along with the close collaboration of their medical team, can help cancer survivors reduce their disease burden and improve their overall wellbeing,” added Erik Augustson, PhD, program director at the National Cancer Institute.

Recommended Reading

Investigational AML drugs boosted remission rates
MDedge Hematology and Oncology
Panobinostat might treat high-risk ALL subtype
MDedge Hematology and Oncology
Combating drug resistance in FLT3-mutated AML
MDedge Hematology and Oncology
Team targets fructose to treat AML
MDedge Hematology and Oncology
Targeting CD98 to treat AML
MDedge Hematology and Oncology
Two-drug combination targets LSCs in CML
MDedge Hematology and Oncology
Team maps genomic landscape of CBF-AML
MDedge Hematology and Oncology
Combo shows promise for treating T-ALL
MDedge Hematology and Oncology
Explaining the development of MPNs, leukemia
MDedge Hematology and Oncology
Combine flow and HTS for sensitive MRD detection in CLL, speaker says
MDedge Hematology and Oncology